Clinical trials: Covert Hepatic Encephalopathy
Liver Cirrhosis, Hepatic Encephalopathy
Diagnosis of Covert/Minimal Hepatic Encephalopathy by Means of Continuous Reaction Time Measurement
The investigators wish to investigate how the Continuous Reaction Time (CRT) method can be used in the diagnosis and monitoring of covert hepatic encephalopathy (cHE)in patients with cirrhosis of the liver.
- Trial name
- NCT01773538
- Testing
- Lactulose and rifaximin, Branched Chain amino acids
- Where
- 2 sites in Denmark
- Volunteers
- 136 people, healthy volunteers welcome
- Sponsor
- Mette Munk Lauridsen
Hepatic Encephalopathy, Covert Hepatic Encephalopathy
Utility of the Clamping Bean Test (CBT) for Covert Hepatic Encephalopathy Screening
Hepatic encephalopathy is a brain dysfunction caused by liver insufficiency and/or porto-systemic shunt. It manifests as a wide spectrum of neurological or psychiatric abnormalities ranging from subclinical alterations to coma.
- Trial name
- NCT06367127
- Where
- China
- Volunteers
- 200 people, healthy volunteers welcome
- Sponsor
- Shanghai Changzheng Hospital
Cirrhosis, Hepatic Encephalopathy
Eye Movement Testing for Diagnosing Encephalopathy in Patients With Liver Disease
This study involves utilizing a noninvasive computer application (Neurofit) that performs oculometric assessment of dynamic visual processing in patients with liver cirrhosis to see if the presence of advance liver disease…
- Trial name
- NCT04940416
- Testing
- Neurofit (oculometric testing)
- Where
- United States
- Volunteers
- 48 people, healthy volunteers welcome
- Sponsor
- Stanford University